Captrust Financial Advisors Vivos Inc Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.07 - $0.12 $10,500 - $18,000	-150,000 Reduced 54.35%	126,000 $11,000
Q1 2021 May 17, 2021	BUY	$0.07 - $0.26 $2,100 - $7,800	30,000 Added 12.2%	276,000 $28,000
Q4 2020 Feb 16, 2021	BUY	$0.02 - $0.21 $400 - $4,200	20,000 Added 8.85%	246,000 $26,000
Q2 2020 Aug 14, 2020	BUY	$0.02 - $0.04 $4,520 - $9,040	226,000 New	226,000 $9,000

Ticker RDGL
Exchange OTC
Sector Healthcare
Industry Medical Devices
Shares Outstandng 359,891,008
Market Cap $61.2M
Description
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.